Actively Recruiting
Stroke-induced Myocardial Dysfunction: Role of GDF-15 (SMOG-15) Clinical Work Package
Led by Centre Hospitalier Universitaire Dijon · Updated on 2025-01-28
130
Participants Needed
1
Research Sites
232 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to analyze the relationship between the blood biomarker GDF-15 and heart damage after stroke. It is being conducted in France, in the Neurology Department of the Dijon University Hospital (Burgundy). The research is interventional because a biological blood test will be performed, as well as a heart rhythm recording and several cardiac echograms during the hospitalization of the participants and during the follow-up consultation scheduled 4 to 6 months after the stroke. A total of 130 stroke patients will participate in this study. Participation includes 4 visits: * Inclusion visit (within 24 hours of the first stroke symptoms) * visit 1 (within 24 to 72 hours of stroke) * visit 2 (within 48 hours of visit 1) * Visit 3 (approximately 4-6 months post-stroke)
CONDITIONS
Official Title
Stroke-induced Myocardial Dysfunction: Role of GDF-15 (SMOG-15) Clinical Work Package
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult with acute symptomatic cerebral infarction documented by brain imaging on admission (cerebral angioscan or cerebral MRI)
- First symptoms appeared within 24 hours before inclusion
- Consent to participate obtained from the patient or a close relative
You will not qualify if you...
- History of symptomatic stroke, either ischemic or hemorrhagic
- History of heart disease including atrial fibrillation or flutter, chronic heart failure, pacemaker, defibrillator, or other cardiac devices
- Acute heart failure, suspected infective endocarditis, STEMI, or concurrent pulmonary embolism
- Not a member or beneficiary of a social security system
- Person deprived of liberty
- Person under legal protection measure (curatorship, guardianship)
- Pregnant, parturient, or breastfeeding woman
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chu Dijon Bourgogne
Dijon, France, 21000
Actively Recruiting
Research Team
Y
Yannick BEJOT
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here